BNP Paribas Financial Markets’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.34M | Buy |
|
|||||
|
2025
Q1 | $901K | Buy |
|
|||||
|
2024
Q4 | $437K | Buy |
|
|||||
|
2023
Q3 | – | Hold |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $115 | Sell |
|
|||||
|
2022
Q4 | $1.33K | Buy |
|
|||||
|
2022
Q3 | $828 | Sell |
|
|||||
|
2022
Q2 | $2.66K | Buy |
|
|||||
|
2022
Q1 | $8.23K | Sell |
|
|||||
|
2021
Q4 | $53K | Buy |
|
|||||
|
2021
Q3 | $85.5K | Buy |
|
|||||
|
2021
Q2 | $32.7K | Sell |
|
|||||
|
2021
Q1 | $55.1K | Sell |
|
|||||
|
2020
Q4 | $69.3K | Sell |
|
|||||
|
2020
Q3 | $70.5K | Buy |
|
|||||
|
2020
Q2 | $17.9K | Sell |
|
|||||
|
2020
Q1 | $37.6K | Buy |
|
|||||
|
2019
Q4 | $24.6K | Sell |
|
|||||
|
2019
Q3 | $26.6K | Buy |
|
|||||
|
2019
Q2 | $14.9K | Sell |
|
|||||
|
2019
Q1 | $32.5K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $5.1K | Hold |
|
|||||
|
2018
Q2 | $5.64K | Buy |
|